HRGN

HARVARD APPRATS REG TCH by Harvard Apparatus Regenerative Technology Inc. (HRGN)

About HARVARD APPRATS REG TCH by Harvard Apparatus Regenerative Technology Inc. (HRGN)

Harvard Apparatus Regenerative Technology, Inc. is a clinical-stage biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. The company was founded by David Green on May 3, 2012 and is headquartered in Holliston, MA.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$2.22
52 Week Low
$0.96
Market cap
21.7M
Dividend yield
0.00%
Volume
--
Avg. volume
555
P/E ratio
-3.06

HARVARD APPRATS REG TCH by Harvard Apparatus Regenerative Technology Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$2.22
52 Week Low
$0.96
Market cap
21.7M
Dividend yield
0.00%
Volume
--
Avg. volume
555
P/E ratio
-3.06